Earnings Feed
Sign Up
Home/Insiders/DOUMANI ROY
DR
SEC Insider//CIK 0001230232

DOUMANI ROY

CIK 00012302322 companiesSANTA MONICA, CA
SEC Profile

Transactions

23

Companies

2

Filings

6

CIK

0001230232

Recent Transactions

23 trades
  • Disposition to Issuer
    Kite Pharma, Inc.

    Director Stock Option (Right to Buy)

    2017-10-03$129.13/sh−7,000→ 0 total
  • Disposition to Issuer
    Kite Pharma, Inc.

    Director Stock Option (Right to Buy)

    2017-10-03$88.79/sh−8,810→ 0 total
  • Disposition from Tender
    Kite Pharma, Inc.

    Common Stock

    2017-10-03$180.00/sh−150,620→ 1,807 total
  • Disposition from Tender
    Kite Pharma, Inc.

    Common Stock

    2017-10-03$180.00/sh−25,065→ 0 total
  • Disposition to Issuer
    Kite Pharma, Inc.

    Common Stock

    2017-10-03−1,807→ 0 total
  • Disposition to Issuer
    Kite Pharma, Inc.

    Director Stock Option (Right to Buy)

    2017-10-03$173.11/sh−30,000→ 0 total
  • Disposition to Issuer
    Kite Pharma, Inc.

    Director Stock Option (Right to Buy)

    2017-10-03$120.77/sh−10,000→ 0 total
  • Award
    Kite Pharma, Inc.

    Common Stock

    2017-06-20+2,410→ 152,427 total
  • Award
    Kite Pharma, Inc.

    Director Stock Option (Right to Buy)

    2017-06-20+8,810→ 8,810 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2017-06-08$84.53/sh−5,000→ 150,017 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2017-06-07$84.46/sh−10,000→ 155,017 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2017-03-01$77.03/sh−6,000→ 115,017 total
  • Exercise/Conversion
    Kite Pharma, Inc.

    Employee Stock Option (Right to Buy)

    2017-03-01−50,000→ 75,065 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2017-03-01$72.27/sh−10,000→ 121,017 total
  • Exercise/Conversion
    Kite Pharma, Inc.

    Common Stock

    2017-03-01$1.35/sh+50,000→ 75,065 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2017-03-01$76.77/sh−2,800→ 25,065 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2016-06-06$58.25/sh−5,000→ 136,017 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2016-06-06$58.38/sh−4,000→ 27,865 total
  • Sale
    Kite Pharma, Inc.

    Common Stock

    2016-06-06$57.56/sh−5,000→ 131,017 total
  • Award
    Kite Pharma, Inc.

    Common Stock

    2016-06-01+1,950→ 141,017 total
  • Award
    Kite Pharma, Inc.

    Director Stock Option (Right to Buy)

    2016-06-01+7,000→ 7,000 total
  • Award
    Kite Pharma, Inc.

    Stock Option (Right to Buy)

    2015-06-09+10,000→ 10,000 total
  • Award
    CTI MOLECULAR IMAGING INC

    Phantom Stock (Deferred Stock Units)

    2004-06-01+3,859→ 8,859 total

Companies

2

Recent Filings

6

Address

C/O KITE PHARMA, INC. 2225 SANTA MONICA AVENUE

SANTA MONICA, CA, 90404

View on SEC.gov